Center for Substance Abuse Prevention; Notice of Meeting, 23501 [2016-09197]

Download as PDF Federal Register / Vol. 81, No. 77 / Thursday, April 21, 2016 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration jstallworth on DSK7TPTVN1PROD with NOTICES Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet via web conference on May 20, 2016, from 10:00 a.m. to 4:30 p.m. E.D.T. The DTAB will convene in both open and closed sessions. On May 20, 2016, from 10:00 a.m. to 12:30 p.m., the meeting will be open to the public. The meeting will include drug testing updates from the Department of Transportation, the Nuclear Regulatory Commission, the Department of Defense, and the Federal Drug-Free Workplace Programs. The public is invited to attend via web conference. Due to the limited callin capacity, registration is requested. Public comments are welcome. To obtain the web conference call-in numbers and access codes, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register at the SAMHSA Advisory Committees Web site at https://nac.samhsa.gov/ Registration/meetingsRegistration.aspx or contact the Charles LoDico (see contact information below). The Board will meet in closed session on May 20, 2016, from 1:00 p.m. to 4:30 p.m., to review and discuss the Proposed Revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine and Oral Fluid). Therefore, this meeting is closed to the public as determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d). Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees Web site, https:// www.samhsa.gov/about-us/advisorycouncils/drug-testing-advisory-boarddtab, or by contacting Mr. LoDico. Committee Name: Substance Abuse and Mental Health Services Administration’s, Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: May 20, 2016, from 10:00 a.m. to 12:30 p.m. E.D.T.: OPEN. May 20, 2016, from 1:00 p.m. to 4:30 p.m. E.D.T.: CLOSED. VerDate Sep<11>2014 13:27 Apr 20, 2016 Jkt 238001 Place: Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Contact: Charles LoDico, M.S., F– ABFT, Division of Workplace Programs, 5600 Fishers Lane, Room 16N02C, Rockville, Maryland 20857, Telephone: 240–276–2600, Fax: 240–276–2610, Email: charles.lodico@samhsa.hhs.gov. Summer King, Statistician, Substance Abuse and Mental Health Services Administration. [FR Doc. 2016–09197 Filed 4–20–16; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection; Comment Request In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA Reports Clearance Officer on (240) 276– 1243. Comments are invited on: (a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Proposed Project: Now Is the Time (NITT)—Project AWARE (Advancing Wellness and Resilience in Education) Evaluation—New SAMHSA is conducting a national evaluation of the Now is the Time (NITT) initiative, which includes separate programs—NITT Project AWARE (Advancing Wellness and Resilience in Education)—State Educational Agency (SEA), Healthy Transitions (HT), and two Minority PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 23501 Fellowship Programs (Youth and Addiction Counselors). These programs are united by their focus on capacity building, system change, and workforce development. NITT—Project AWARE, which is the focus of this data collection, represents a response to the third and fourth components of President Obama’s NITT Initiative: Making schools safer and focusing on access to mental health services. The goal of NITT—Project AWARE is to develop a comprehensive, coordinated, and integrated program for advancing wellness and resilience in educational settings for school-aged youth. SAMHSA awarded NITT—Project AWARE grants to 20 SEAs. Each SEA proposed partnerships between at least three high-need Local Educational Agencies (LEAs) to develop a coordinated and integrated plan of services and strategies to address the Project NITT—Project AWARE–SEA goals and objectives. Project AWARE grantees will plan and implement activities designed to increase the capacity of SEAs in three areas: (1) Increase mental health awareness among school-aged (K–12) youth; (2) train those who work with school-aged children to identify and respond to mental health issues in children and young adults; and (3) connect children, youth, and families with mental health services. The intention is to encourage cross-system collaboration and use evidence-based strategies to address mental health needs. The Project AWARE evaluation will examine the process and outcomes of activities by SEA grantees and their LEA and school partners. It will evaluate the capacity of SEAs to effectively involve family and youth, provide a culturally and linguistically competent and family-centered mental health service array, and implement a process for identifying need and delivering services that is informed by data and coordinated across child-serving agencies. Evaluation questions have been developed to understand grantee context, planning, implementation, outputs, and outcomes across each of the NITT priority areas. Data collection efforts that will support the evaluation are described below. AWARE Planning and Implementation Activities Inventory (AWARE Activities Inventory), to capture information about all activities supported by Project AWARE resources during the grant period. The inventory will be reviewed and updated on an annual basis at the SEA level with the grant project director, at the LEA level with the grant program coordinators, E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 81, Number 77 (Thursday, April 21, 2016)]
[Notices]
[Page 23501]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-09197]



[[Page 23501]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet via web conference on May 20, 2016, from 10:00 
a.m. to 4:30 p.m. E.D.T. The DTAB will convene in both open and closed 
sessions.
    On May 20, 2016, from 10:00 a.m. to 12:30 p.m., the meeting will be 
open to the public. The meeting will include drug testing updates from 
the Department of Transportation, the Nuclear Regulatory Commission, 
the Department of Defense, and the Federal Drug-Free Workplace 
Programs.
    The public is invited to attend via web conference. Due to the 
limited call-in capacity, registration is requested. Public comments 
are welcome. To obtain the web conference call-in numbers and access 
codes, submit written or brief oral comments, or request special 
accommodations for persons with disabilities, please register at the 
SAMHSA Advisory Committees Web site at https://nac.samhsa.gov/Registration/meetingsRegistration.aspx or contact the Charles LoDico 
(see contact information below).
    The Board will meet in closed session on May 20, 2016, from 1:00 
p.m. to 4:30 p.m., to review and discuss the Proposed Revisions to the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs (Urine 
and Oral Fluid). Therefore, this meeting is closed to the public as 
determined by the Administrator, SAMHSA, in accordance with 5 U.S.C. 
552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d).
    Meeting information and a roster of DTAB members may be obtained by 
accessing the SAMHSA Advisory Committees Web site, https://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab, or by contacting Mr. LoDico.
    Committee Name: Substance Abuse and Mental Health Services 
Administration's, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type:
    May 20, 2016, from 10:00 a.m. to 12:30 p.m. E.D.T.: OPEN.
    May 20, 2016, from 1:00 p.m. to 4:30 p.m. E.D.T.: CLOSED.
    Place: Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 
20857.
    Contact: Charles LoDico, M.S., F-ABFT, Division of Workplace 
Programs, 5600 Fishers Lane, Room 16N02C, Rockville, Maryland 20857, 
Telephone: 240-276-2600, Fax: 240-276-2610, Email: 
charles.lodico@samhsa.hhs.gov.

Summer King,
Statistician, Substance Abuse and Mental Health Services 
Administration.
[FR Doc. 2016-09197 Filed 4-20-16; 8:45 am]
 BILLING CODE 4162-20-P